002020 京新藥業
按盤價 
14.660 +1.330 (+9.977%)
14.660 +1.330 (+9.977%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.770 | 12.844 | 12.401 | 11.613 | 13.235 |
| 總資產報酬率 ROA (%) | 2.042 | 9.131 | 8.648 | 8.064 | 9.522 |
| 投入資產回報率 ROIC (%) | 2.547 | 11.557 | 10.975 | 10.130 | 11.708 | 邊際利潤分析 |
| 銷售毛利率 (%) | 51.083 | 50.149 | 49.974 | 50.573 | 53.275 |
| 營業利潤率 (%) | 21.032 | 21.199 | 20.286 | 17.857 | 20.017 |
| 息稅前利潤/營業總收入 (%) | 20.901 | 20.130 | 18.746 | 16.360 | 17.937 |
| 淨利潤/營業總收入 (%) | 18.000 | 18.840 | 17.293 | 15.590 | 17.668 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.603 | 97.291 | 93.439 | 89.232 | 92.627 |
| 價值變動淨收益/利潤總額(%) | 0.816 | 3.075 | -3.959 | 6.103 | 5.780 |
| 營業外收支淨額/利潤總額(%) | -1.441 | 0.193 | 0.044 | -0.850 | -0.840 | 償債能力分析 |
| 流動比率 (X) | 2.031 | 1.731 | 1.361 | 1.616 | 1.807 |
| 速動比率 (X) | 1.513 | 1.329 | 0.989 | 1.302 | 1.381 |
| 資產負債率 (%) | 23.901 | 27.737 | 29.221 | 30.631 | 29.753 |
| 帶息債務/全部投入資本 (%) | 1.366 | 3.942 | 5.566 | 6.452 | 6.879 |
| 股東權益/帶息債務 (%) | 6,824.745 | 2,300.406 | 1,604.489 | 1,358.410 | 1,261.677 |
| 股東權益/負債合計 (%) | 316.405 | 258.871 | 240.923 | 225.326 | 234.920 |
| 利息保障倍數 (X) | 124.220 | -18.139 | -12.098 | -12.154 | -9.375 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 73.915 | 67.811 | 57.105 | 47.079 | 44.518 |
| 存貨周轉天數 (天) | 157.480 | 138.318 | 125.062 | 129.902 | 147.920 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 02/07/2026 15:25 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
